Masimo, a medical technology company, announced today its device aimed at reducing the symptoms associated with opioid withdrawal.
The device, called Bridge, is a wearable, single-patient-use, percutaneous neurostimulator which is situated behind the ear. It applies electrical impulses to the cranial nerves around the ear, which can reduce neuron activity and reduce opioid withdrawal symptoms,...
DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal.
The device, called Drug Relief, is now available to providers in the US, and is distributed in the EU by the DyAnsys’ European branch.
"This device offers hope to...
